| Autonomix Medical, Inc. (AMIX) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | |||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2026 | Q3-FY2026 | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | |||||||||||||||||||||||||||||||||||||||
| Price to Sales | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||
| Price to Book | .77x | .74x | .44x | .86x | .62x | .53x | .45x | 4.50x | 3.60x | 7.12x | |||||||||||||||||||||||||||||||||||||||
| Price to Earnings | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||
| Debt to Asset Ratio | .22x | .16x | .19x | .22x | .17x | .19x | .44x | .25x | .19x | 4.09x | .26x | ||||||||||||||||||||||||||||||||||||||
| Current Ratio | 4.45x | 6.18x | 5.31x | 4.57x | 5.63x | 5.31x | 4.26x | 9.27x | 12.09x | 1.73x | 3.91x | ||||||||||||||||||||||||||||||||||||||